Anti-CD47 Reference Antibody (letaplimab)
- Product Code: 139895
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in cancer immunotherapy to block the CD47 protein on tumor cells, which helps cancer evade the immune system. By inhibiting CD47, the antibody enables macrophages and other immune cells to recognize and destroy cancer cells more effectively. Investigated in clinical trials for hematologic malignancies such as leukemia and lymphoma, as well as solid tumors. Often studied in combination with other monoclonal antibodies like rituximab or cetuximab to enhance phagocytosis and anti-tumor activity. Also explored for use in myelodysplastic syndromes and acute myeloid leukemia.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CD47 Reference Antibody (letaplimab)
Used in cancer immunotherapy to block the CD47 protein on tumor cells, which helps cancer evade the immune system. By inhibiting CD47, the antibody enables macrophages and other immune cells to recognize and destroy cancer cells more effectively. Investigated in clinical trials for hematologic malignancies such as leukemia and lymphoma, as well as solid tumors. Often studied in combination with other monoclonal antibodies like rituximab or cetuximab to enhance phagocytosis and anti-tumor activity. Also explored for use in myelodysplastic syndromes and acute myeloid leukemia.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :